U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Michael Todd Beauty LP - 04/05/2017
  1. Warning Letters

CLOSEOUT LETTER

Michael Todd Beauty LP

Recipient:
Michael Todd Beauty LP

United States

Issuing Office:

United States

 

  

Black HHS-Blue FDA Logo

 

 

 
Florida District
555 Winderley Place, Suite 200
Maitland, Florida 32751 

April 05, 2017

VIA UPS NEXT DAY AIR
w/ DELIVERY CONFIRMATION

Lewis Hendler, Chairman
Michael Todd Beauty LP
648 SW Port St. Lucie Blvd
Port St. Lucie, FL 34953

Dear Mr. Hendler:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter [FLA-16-18, July 18, 2016]. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Susan M. Turcovski
Director, Florida District

Cc:
Mark C. Levy, Esq.
Eckert Seamans Cherin & Mellott, LLC
Two Liberty Place
50 South 16th Street 22nd Floor
Philadelphia, PA 19102
 

Back to Top